Cardiac Diagnostic Procedure

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

CH
Cardinal HealthOH - Dublin
1 program
1
Mynx Vascular Closure SystemPhase 41 trial
Active Trials
NCT02438475Completed208Est. Aug 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Cardinal HealthMynx Vascular Closure System

Clinical Trials (1)

Total enrollment: 208 patients across 1 trials

NCT02438475Cardinal HealthMynx Vascular Closure System

The Safety and Efficacy of an Extravascular, Water-Soluble Sealant for Venous Access-Site Closure

Start: Jun 2015Est. completion: Aug 2017208 patients
Phase 4Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space